Biostar Pharmaceuticals (BSPM) Reports Q3 Earnings of $0.16; Reaffirms Outlook
Tweet Send to a FriendGet Alerts BSPM Hot Sheet
Trade BSPM Now!
Biostar Pharmaceuticals (NASDAQ: BSPM) reported Q3 EPS of $0.16, versus $0.13 reported last year. Revenue for the quarter came in at $24.78 million, versus $20.18 million reported last year.
Reaffirms outlook.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Reaffirms outlook.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Nordson Corp (NDSN) Reports In-Line Q2 EPS, Q3 Guidance Falls Short
- Mentor Graphics Corp (MENT) Tops Q1 EPS by 5c; Guides Q2, FY14
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
